Campbell Alliance to Co-Chair and Speak at SRI’s 11th Annual Pharma & Biotech Licensing Deal-Making Summit

March 23, 2006



Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industries, today announced that Ben Bonifant, Senior Practice Executive and head of its Business Development practice, will serve as co-chairperson and speak at the Strategic Research Institute’s (SRI) 11th Annual Pharma & Biotech Licensing Deal-Making Summit to be held on March 27-29, 2006 at the La Jolla Marriott in San Diego. 


Mr. Bonifant will open the main conference sessions with an introductory address at 8:20am on March 28 and then present a session titled “Building and Managing the Ultimate Business Development Pipeline” at 12:05pm.  During this session, he will suggest a process that companies can use to identify prospects and manage relationships with potential partners.  Delegates attending his one-hour session will learn how to


  • Implement a customer relationship management-based approach to BD pipeline management
  • Apply a marketing approach to position a BD organization as a “partner of choice”
  • Establish a tracking and reporting system that can help prevent in-licensing opportunities from “falling through the cracks" and in following up leads


“In today's increasingly competitive pharmaceutical licensing environment, companies must be able to move quickly to identify, evaluate, and negotiate deals that create shareholder value.  We’ve found that some of the most successful companies have a systematic approach toward proactively identifying in-licensing opportunities and managing them to successful closure,” stated Bonifant.


In its 11th year, the SRI Pharma & Biotech Licensing Deal-Making Summit typically attracts close to 200 executives in business development, licensing, and corporate development roles, as well as delegates from the investment and university technology transfer communities.  For more information, please visit



About the Business Development Practice at Campbell Alliance


The Business Development Practice at Campbell Alliance helps licensing executives achieve an edge over the competition.  Our consultants provide experienced counsel to clients who need assistance developing business development strategies, identifying partners, prioritizing targets, evaluating opportunities, and negotiating deals.


The firm’s team members include seasoned professionals in pharmaceutical and biotech business development.  As consultants and industry professionals, they’ve identified, assessed, and executed numerous in-licensing deals, assisted out-licensors, helped clients improve internal processes for pharmaceutical business development, and helped top executives chart new strategies in corporate development.



About Campbell Alliance


Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries.  The firm's clients include most of the world's "top 20" pharmaceutical companies, as well as numerous emerging and midsize firms.  Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, and Sales.  From its locations in Raleigh, N.C., Parsippany, N.J., Woodland Hills, Calif., San Bruno, Calif., and New York City, the firm serves clients throughout North America, Europe, and Japan.  For more information on Campbell Alliance, please visit

inVentiv Health Consulting offers world class healthcare consulting services.

Media Contact:

Stephanie Koenig